Why would Arm's owner want to buy a rival to AMD and Intel? I can think of one reason

Full Article
Why would Arm's owner want to buy a rival to AMD and Intel? I can think of one reason

SoftBank is reportedly in discussions to acquire Ampere Computing, a company known for its advanced data center chips built on Arm architecture. This potential acquisition aims to position SoftBank as a formidable competitor against industry giants like AMD and Intel, especially in the context of the growing AI investment landscape. The deal's uncertainty reflects the challenges and ambitions of SoftBank in the rapidly evolving tech market.

Ampere Computing's expertise in AI and data center technology could significantly enhance Arm's capabilities, transitioning from merely licensing chip designs to becoming a full-fledged chipmaker. The integration of Ampere's processors with SoftBank's existing AI accelerators could create competitive systems tailored for demanding data center workloads. However, Ampere's preparations for an IPO and the need for approval from its stakeholders, including Oracle and Carlyle Group, add complexity to the acquisition process.

• SoftBank aims to rival AMD and Intel through Ampere acquisition.

• Ampere's chips are crucial for AI-driven data center solutions.

Key AI Terms Mentioned in this Article

Data Center

Data centers are facilities used to house computer systems and associated components, crucial for AI workloads.

AI Accelerators

AI accelerators are hardware designed to speed up AI computations, enhancing performance in data centers.

Companies Mentioned in this Article

SoftBank

SoftBank is a major stakeholder in Arm and is pursuing Ampere to strengthen its AI capabilities.

Ampere Computing

Ampere Computing specializes in data center chips and is pivotal for AI applications in the tech industry.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 7month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 7month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 7month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 7month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics